Data / Drug companies / Metoprolol succinate
Metoprolol succinate: 46 companies and 226 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Metoprolol succinate is listed in the FDA National Drug Code Directory by 46 companies, with 226 products in commercial distribution. 212 of the products (93.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, film coated, extended release; capsule, extended release, and the newest product started marketing on July 6, 2026.
The request: Get every company that lists metoprolol succinate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 46
- Products
- 226
- Generic (ANDA) products
- 212 (93.8%)
- Application numbers
- 14
- Routes
- Oral
- Brand names
- Toprol XL, Kapspargo
- openFDA record search
- api.fda.gov
Companies that list metoprolol succinate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 16 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | October 2, 2023 |
| Bryant Ranch Prepack | 15 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | July 21, 2025 |
| BluePoint Laboratories | 12 | tablet, extended release | Generic drugs (ANDA) | March 1, 2026 |
| Remedyrepack Inc. | 10 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | December 9, 2025 |
| Proficient Rx LP | 9 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | November 6, 2020 |
| Oryza Pharmaceuticals Inc. | 8 | tablet, extended release | Generic drugs (ANDA) | May 15, 2026 |
| Northwind Health Company, LLC | 7 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | April 20, 2023 |
| NuCare Pharmaceuticals,Inc. | 7 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | October 2, 2023 |
| Cardinal Health 107, LLC | 6 | tablet, film coated, extended release | Generic drugs (ANDA) | February 24, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 5 | tablet, extended release | Generic drugs (ANDA) | February 6, 2018 |
| Proficient Rx LP | 5 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | October 2, 2023 |
| Redpharm Drug | 5 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | October 2, 2023 |
| Actavis Pharma, Inc. | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | February 3, 2020 |
| AvPAK | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | July 25, 2018 |
| Camber Pharmaceuticals, Inc. | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | November 6, 2020 |
| Coupler LLC | 4 | tablet, extended release | Generic drugs (ANDA) | July 6, 2026 |
| Cranbury Pharmaceuticals, LLC | 4 | tablet, extended release | Generic drugs (ANDA) | June 1, 2025 |
| Dr. Reddy's Laboratories Inc. | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | January 13, 2026 |
| Dr. Reddy's Laboratories Limited | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | September 10, 2012 |
| Epic Pharma, LLC | 4 | tablet, extended release | Generic drugs (ANDA) | February 1, 2025 |
| Golden State Medical Supply, Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | February 6, 2018 |
| Granules India Limited | 4 | tablet, extended release | Generic drugs (ANDA) | August 1, 2025 |
| Granules Pharmaceuticals Inc. | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | October 2, 2023 |
| Ingenus Pharmaceuticals, LLC | 4 | tablet, extended release | Generic drugs (ANDA) | February 6, 2018 |
| Melinta Therapeutics, LLC | 4 | tablet, extended release | New drug applications (NDA) | July 3, 2023 |
| NorthStar RxLLC | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | April 10, 2023 |
| Northwind Health Company, LLC | 4 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | September 15, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | October 2, 2023 |
| Preferred Pharmaceuticals Inc. | 4 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | September 5, 2025 |
| Quallent Pharmaceuticals Health LLC | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | July 20, 2023 |
| Slate Run Pharmaceuticals, LLC | 4 | tablet, extended release | Generic drugs (ANDA) | October 28, 2022 |
| St. Mary's Medical Park Pharmacy | 4 | tablet, extended release | Generic drugs (ANDA) | October 15, 2025 |
| Sun Pharmaceutical Industries, Inc. | 4 | capsule, extended release | New drug applications (NDA) | February 7, 2018 |
| Sun Pharmaceutical Industries, Inc. | 4 | capsule, extended release | New drug applications (NDA) | March 15, 2018 |
| Zydus Lifesciences Limited | 4 | tablet, extended release | Generic drugs (ANDA) | June 7, 2018 |
| Zydus Pharmaceuticals USA Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | June 7, 2018 |
| American Health Packaging | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | March 15, 2019 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | January 13, 2026 |
| Cipla USA Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | March 25, 2019 |
| Major Pharmaceuticals | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | September 10, 2012 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 3 | tablet, extended release | Generic drugs (ANDA) | September 10, 2012 |
| Zhejiang Jutai Pharamceutical Co., Ltd | 3 | tablet, extended release | Generic drugs (ANDA) | November 16, 2020 |
| Bryant Ranch Prepack | 2 | tablet, extended release | Generic drugs (ANDA) | June 7, 2018 |
| Direct RX | 2 | tablet, extended release | Generic drugs (ANDA) | January 19, 2021 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | September 10, 2012 |
| Proficient Rx LP | 1 | tablet, extended release | Generic drugs (ANDA) | September 10, 2012 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 132 | 58.4% |
| Tablet, film coated, extended release | 86 | 38.1% |
| Capsule, extended release | 8 | 3.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 212 | 93.8% |
| New drug applications (NDA) | 13 | 5.8% |
| Authorized generics (NDA) | 1 | 0.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| beta-Adrenergic Blocker | 226 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.